Moderna would seek limited emergency use of COVID-19 vaccine based on early data

CHICAGO: If Moderna's COVID-19 vaccine proves to be at least 70 per cent effective, the company plans to seek emergency authorisation for its use in high-risk groups, the company's chief executive told Reuters.

"If the interim readout is deemed by the independent safety committee as positive with 70 or 80 or 90 per cent efficacy, we will indeed consider approval," Stephane Bancel, Moderna's chief executive officer, said in a telephone interview."At such a level of efficacy, if we get there, we can protect a lot of lives in the people at the highest risk, and so, we will consider filing for an EUA for a very limited population," Bancel said.

The two groups of high-risk individuals who might be covered in such an EUA would be healthcare workers and the elderly, Bancel said. Public health officials have said that approving a vaccine for widespread use based on a small number of cases would not offer enough safety information to show how the vaccine would perform.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China suspends poultry imports from second US plant over COVID-19, industry group saysCHICAGO: China has suspended imports from an OK Foods poultry plant in Fort Smith, Arkansas, because of coronavirus cases among workers, the USA ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Q&M unit gets lab licence to conduct testing services for Covid-19A SUBSIDIARY of Q&M Dental Group has been granted a healthcare institution licence from the Ministry of Health to operate a clinical laboratory to conduct SARS-CoV-2 polymerase chain reaction (PCR) testing services for Covid-19. SARS-CoV-2 is the virus that causes the Covid-19 disease. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »